HUMA

NASD Humacyte, Inc.
Oct 13, 2026 · 1:22 AM ET EOD Market Closed

$0.3896 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3896, $0.0234 below the day’s high of $0.4130

YTD change
-59.44%
vs 20-day SMA
-26.72%
vs 200-day SMA
-54.54%

Price ranges

Previous day
$0.3910 $0.4490
open $0.4400 close $0.4053
-$0.0347 (-7.89%)
Today
$0.3868 $0.4130
open $0.4000 now $0.3896
-$0.0104 (-2.60%)
Past week
$0.3910 $0.5223
from $0.5215 now $0.3896
-$0.1319 (-25.29%)
Past month
$0.3910 $0.6099
from $0.5676 now $0.3896
-$0.1780 (-31.36%)
This year
$0.3868 $1.5250
from $0.9605 now $0.3896
-$0.5709 (-59.44%)

Price & Performance

-0.28 (-41.86%) / 6M

$0.3016$0.7271$1.15$1.58Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.8% away from all-time highs of $17.4500
  • HUMA is down 59% since the beginning of the year
  • HUMA is down 75% over the past 12 months
  • HUMA is down 31% over the past 1 month
  • 12% of all HUMA investors are betting against HUMA

HUMA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -77.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.16
Earnings momentum -65.4% Quarterly EPS growth
Quarterly change -65.4%

Valuation

P/E ratio N/A
Enterprise value $81.0M
Beta 4.78

Balance sheet & scale

IncomeN/A
Revenue$2.1M
Cash$80.0M
Debt$66.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $108.2M

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $417.57 +0.65%
MRNA Moderna, Inc. $213.74 -5.00%
RVMD Revolution Medicines, Inc. $193.95 +2.21%
ROIV Roivant Sciences Ltd. $34.59 -2.40%
BNTX BioNTech SE Sponsored ADR $95.84 -1.16%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.